We found that co-occurrence of LC-MBL and CHIP was associated with a significant 4.7-fold increased risk of lymphoid malignancy compared to a significant 2.6-fold risk among those with LC-MBL alone. The gene discussed is STUB1; the disease is laryngotracheoesophageal cleft.